Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents

The high effectiveness of the third dose of BNT162b2 in healthy adolescents against Omicron BA.1 has been reported in some studies, but immune responses conferring this protection are not yet elucidated. In this analysis, our study (NCT04800133) aims to evaluate the humoral and cellular responses ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Xiaofeng, Cohen, Carolyn A., Leung, Daniel, Rosa Duque, Jaime S., Cheng, Samuel M. S., Chung, Yuet, Wong, Howard H. W., Lee, Amos M. T., Li, Wing Yan, Tam, Issan Y. S., Lam, Jennifer H. Y., Lee, Derek H. L., Chan, Sau Man, Tsang, Leo C. H., Chan, Karl C. K., Li, John K. C., Luk, Leo L. H., Chaothai, Sara, Kwan, Kelvin K. H., Chu, Nym Coco, Mori, Masashi, Jeevan, Trushar, Kandeil, Ahmed, Webby, Richard J., Tu, Wenwei, Valkenburg, Sophie A., Peiris, Malik, Lau, Yu Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748396/
https://www.ncbi.nlm.nih.gov/pubmed/36517469
http://dx.doi.org/10.1038/s41392-022-01282-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748396/
https://www.ncbi.nlm.nih.gov/pubmed/36517469
http://dx.doi.org/10.1038/s41392-022-01282-7

Ejemplares similares